- Home
- Publications
- Publication Search
- Publication Details
Title
Lenalidomide in multiple myeloma
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 15, Issue 5, Pages 491-497
Publisher
Informa UK Limited
Online
2015-04-06
DOI
10.1586/14737140.2015.1033407
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide, an antiproliferative CLL drug
- (2014) M. Seiffert BLOOD
- Recent developments in myelodysplastic syndromes
- (2014) R. Bejar et al. BLOOD
- Novel Drug Combinations for the Management of Relapsed/Refractory Multiple Myeloma
- (2014) Saad Z. Usmani et al. Clinical Lymphoma Myeloma & Leukemia
- Biology and Treatment of Myeloma
- (2014) Annamaria Brioli et al. Clinical Lymphoma Myeloma & Leukemia
- European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
- (2014) M. Engelhardt et al. HAEMATOLOGICA
- Allogeneic Stem Cell Transplantation for Multiple Myeloma
- (2014) William Bensinger HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Multiple Myeloma
- (2014) Sarah A. Holstein et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
- (2014) Nathan H Fowler et al. LANCET ONCOLOGY
- Current treatment landscape for relapsed and/or refractory multiple myeloma
- (2014) Meletios A. Dimopoulos et al. Nature Reviews Clinical Oncology
- Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs
- (2014) Philip P Chamberlain et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Treatment of Multiple Myeloma: Thalidomide-, Bortezomib-, and Lenalidomide-Induced Peripheral Neuropathy
- (2014) Susanne Koeppen Oncology Research and Treatment
- Multiple myeloma maintenance therapy: A review of the pharmacologic treatment
- (2014) Brandon R Shank et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma
- (2013) M. Wang et al. BLOOD
- Peripheral neuropathy in multiple myeloma patients receiving lenalidomide, bortezomib, and dexamethasone (RVD) therapy
- (2013) P. M. Voorhees et al. BLOOD
- Sorafenib in patients with refractory or recurrent multiple myeloma
- (2013) Anna Yordanova et al. HEMATOLOGICAL ONCOLOGY
- New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
- (2013) E M Ocio et al. LEUKEMIA
- Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis
- (2013) Flora Zagouri et al. LEUKEMIA & LYMPHOMA
- Efficacy of lenalidomide in POEMS syndrome: A retrospective study of 20 patients
- (2012) Bruno Royer et al. AMERICAN JOURNAL OF HEMATOLOGY
- Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses
- (2012) Kimberly Noonan et al. CLINICAL CANCER RESEARCH
- In vivo efficacy of the diuretic agent ethacrynic acid against multiple myeloma
- (2012) Young Kim et al. LEUKEMIA RESEARCH
- Lenalidomide for Multiple Myeloma
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
- (2012) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide
- (2011) A. Larocca et al. BLOOD
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
- (2011) Y. X. Zhu et al. BLOOD
- Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
- (2011) M A Dimopoulos et al. LEUKEMIA
- Management of treatment-emergent peripheral neuropathy in multiple myeloma
- (2011) P G Richardson et al. LEUKEMIA
- Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant
- (2011) Francesco Spina et al. LEUKEMIA & LYMPHOMA
- Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment
- (2010) Ulrike Klein et al. ANNALS OF HEMATOLOGY
- Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)
- (2010) J. A. Zonder et al. BLOOD
- Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone
- (2010) Jesús F. San-Miguel et al. Clinical Lymphoma Myeloma & Leukemia
- Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function
- (2010) A. K. Gandhi et al. CURRENT CANCER DRUG TARGETS
- Managing the teratogenic risk of thalidomide and lenalidomide: an industry perspective
- (2010) Robert Bwire et al. Expert Opinion On Drug Safety
- Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma
- (2010) J.-L. Harousseau et al. HAEMATOLOGICA
- Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial
- (2010) Maria-Victoria Mateos et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
- (2010) Michel Delforge et al. LANCET ONCOLOGY
- Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma
- (2010) Jens Hasskarl et al. LEUKEMIA & LYMPHOMA
- In vivo efficacy of griseofulvin against multiple myeloma
- (2010) Young Kim et al. LEUKEMIA RESEARCH
- Relapse/Refractory Myeloma Patient: Potential Treatment Guidelines
- (2009) Jesús F. San Miguel JOURNAL OF CLINICAL ONCOLOGY
- Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma
- (2009) M A Dimopoulos et al. LEUKEMIA
- The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
- (2008) Christine Galustian et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started